Detalhe da pesquisa
1.
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancer.
Breast Cancer Res Treat
; 195(1): 55-64, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35829935
2.
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients.
Breast Cancer Res Treat
; 192(3): 629-637, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113257
3.
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials.
Cancer Sci
; 112(6): 2381-2392, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686753
4.
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study.
Breast Cancer Res Treat
; 187(3): 759-768, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860389
5.
Reconstructive outcome analysis of the impact of neoadjuvant chemotherapy on immediate breast reconstruction: a retrospective cross-sectional study.
BMC Cancer
; 21(1): 522, 2021 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964927
6.
Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
BMC Surg
; 21(1): 160, 2021 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33757489
7.
Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells.
BMC Cancer
; 19(1): 176, 2019 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30808421
8.
Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status.
BMC Cancer
; 17(1): 863, 2017 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254480
9.
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 17(3): 357-366, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26822398
10.
Immune modulation of CD4+CD25+ regulatory T cells by zoledronic acid.
BMC Immunol
; 17(1): 45, 2016 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27887569
11.
Presurgical symptom profiles predict quality of life 2 years after surgery in women with breast cancer.
Support Care Cancer
; 24(1): 243-251, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26014617
12.
Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years.
J Formos Med Assoc
; 115(4): 249-56, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25900861
13.
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
Int J Mol Sci
; 17(4)2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27110769
14.
Predictors of underestimation of malignancy after image-guided core needle biopsy diagnosis of flat epithelial atypia or atypical ductal hyperplasia.
Breast J
; 21(3): 224-32, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25772033
15.
Change and predictors of symptom distress in breast cancer patients following the first 4 months after diagnosis.
J Formos Med Assoc
; 114(3): 246-53, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23871549
16.
Monitoring patient-centered outcomes through the progression of breast reconstruction: a multicentered prospective longitudinal evaluation.
Breast Cancer Res Treat
; 146(2): 299-308, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24951266
17.
Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan.
Hepatol Int
; 18(2): 449-460, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376651
18.
The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience.
Breast Cancer
; 31(2): 252-262, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38150135
19.
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 10(3): 325-334, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127335
20.
Cardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged Sword.
Acta Cardiol Sin
; 29(4): 295-303, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27122721